Skip to main content

Advertisement

Table 1 Demographic and clinical characteristics

From: Echocardiographic assessment of asymptomatic US Air Force members with early HIV infection

CharacteristicAll subjects (n = 50)
Age at HIV diagnosis (years)28 (7.14)
Gender, male48 (96)
Race/ethnicity
 African American30 (60)
 Caucasian18 (36)
 Other2 (4)
 Body-mass index (kg/m2)25.4 (3.66)
 Obese4 (8)
 Active smoker10 (20)
 Hypertension4 (8)
 Diabetes mellitus
 Hyperlipidemia5 (10)
 Family history of cardiovascular disease11 (22)
 hs-CRP (mg/dL)1.6 (2)
 NT-proBNP (pg/mL)19.6 (39.7)
Echocardiographic findings
 Left ventricle 
 LV ejection fraction (%)63.4 (6)
 GLS (%)− 0.31 (2.73)
 LV remodelinga13 (26)
 LV diastolic dysfunction1 (2)
 Indexed LV mass (g/m2)70 (13.9)
 Interventricular septal diameter (mm)8.6 (1.8)
 Relative wall thickness0.37 (0.07)
Right ventricle
 Indexed RV area (cm2/m2)11.2 (2.1)
 FAC (%)43.4 (7)
 RV dilatationb7 (14)
LV diastolic function
 Indexed LA volume (cm2/m2)20.1 (6.3)
 Septal e′ velocity (cm/s)11.4 (2.3)
 Lateral e′ velocity (cm/s)15.9 (3.2)
 Average E/e′5.9 (1.5)
 Pulmonary artery systolic pressure (mmHg)22.5 (3.7)
HIV disease characteristics
 CD4 count (cells/μL)551 (225.1)
 HIV viral load (copies/mL)c112,585 (217,965)
 AIDS diagnosisd2 (4)
 Time from last HIV negative test to first positive HIV test (days)530 (265.2)
 Estimated duration of infection prior to clinical evaluation (days)304 (129.4)
  1. All data expressed as number (%) or mean (± SD)
  2. hs-CRP high-sensitivity C-reactive protein, NT-proBNP N-terminal probrain natriuretic peptide, LV left ventricular, GLS global longitudinal strain, RV right ventricular, LA left atrial, FAC fractional area change, E/e′ early mitral inflow velocity/mitral annular early diastolic velocity
  3. aLeft ventricular remodeling was defined as relative wall thickness of > 0.42
  4. bDetermined by indexed diastolic RV area
  5. cViral load data excluded for 1 patient with viral load greater than the upper assay limit (> 1 × 107 copies/mL)
  6. dAIDS diagnostic criteria met by CD4 count < 200 cells/μL and or < 14%